Clarivate Plc

Clarivate Plc engages in the provision of global information, analytics and workflow solutions. It operates through the Science and Intellectual Property segments. The Science segment is composed of the academia and government, and life science and healthcare product lines. The Intellectual Property segment includes the patent, trademark, domain, and IP management product lines. The company was founded in 1864 and is headquartered in London, the United Kingdom.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Clarivate Plc reports strong Q4 earnings, eyes growth opportunities

Clarivate Plc delivered strong financial results in Q4 2022, driven by the successful ProQuest acquisition and solid organic growth across segments. The company is focused on achieving higher organic growth, reducing leverage, and leveraging culture for success.
While facing macroeconomic challenges and pricing pressures, Clarivate Plc is confident in its strategic plans and capital structure initiatives. Opportunities lie in leveraging AI, enhancing product offerings, and capitalizing on the positive pricing environment.
Navigating challenges such as tough comps, managing inflation impact, and balancing quarterly patterns will be crucial. The company's proactive approach to growth, focus on customer value, and upcoming Investor Day position it well for future success.

Clarivate Plc reports stable Q1 performance amidst growth challenges

Clarivate Plc's Q1 2023 performance showcased stable revenue, strong margins, and strategic financial initiatives despite challenges in net income and organic growth cadence.
The company's strengths lie in market engagement, AI innovation, maintained outlook, and effective pricing strategies, positioning it for continued growth.
Challenges include earnings volatility, execution hurdles in growth projections, and longer-term segment revenue impacts, necessitating strategic planning and operational focus.
Opportunities in AI applications, cash flow utilization, revenue drivers, and segment progress offer avenues for revenue diversification, growth investments, and market expansion.

Clarivate Plc faces revenue challenges but drives growth through innovation

Clarivate Plc's Q2 performance saw challenges in key segments impacting revenue and outlook, despite operational improvements and strategic initiatives.
While facing hurdles in patent annuities and commercialization subsegment growth, the company focuses on sustainability, product innovations, and customer-centric strategies for future growth.
Detailed financial results and revised guidance reflect the company's proactive approach to address challenges and capitalize on opportunities for sustainable growth.
With a pivot around three segments and emphasis on higher-touch sales, Clarivate aims to navigate challenges, leverage opportunities, and drive revenue growth in the evolving market landscape.

Clarivate Plc reports Q3 growth, tackles challenges, eyes tech acquisitions

Clarivate Plc's Q3 performance showed growth in key segments despite challenges in IP and LS&H businesses.
Opportunities lie in technology acquisitions, analytic platforms, and direct sales to pharma companies.
Management remains optimistic about quarterly results and progress, focusing on enhancing growth strategies.

Clarivate Plc reports solid Q4 performance amidst sector challenges

Clarivate Plc's Q4 2023 performance reflects progress in key segments and a strategic focus on organic growth and operational efficiencies.
While facing challenges in the A&G segment and market conservatism, the company is leveraging strengths in Life Sciences investments and pricing strategies.
Opportunities lie in growth acceleration through new offerings, improved organic growth, and renewed optimism in the life sciences sector.

Clarivate Plc reports Q1 revenue growth, eyes segment expansion

Clarivate Plc's Q1 performance showed promising organic revenue growth and steady renewal rates, with a focus on future investments for growth.
While facing financial challenges and neutral market conditions, the company sees opportunities in segment growth and real-world data solutions.
Overall, Clarivate remains on track with full-year guidance, aiming for 1% organic growth and focusing on driving subscription business growth.

Clarivate Plc reports mixed Q2 results, focuses on growth strategies

Clarivate Plc reported mixed financial results in Q2 2024, with slight revenue growth but challenges in certain segments.
Management emphasized resilience in adjusted EPS and operating cash flow, focusing on growth plans and operational improvements.
Analysts raised concerns about project delays and segment performance, but opportunities in product innovation and revenue growth were highlighted.
The company aims to drive subscription revenue growth through upcoming product releases and investment in business.

Clarivate Plc faces revenue decline in Q3 but focuses on growth strategies

Clarivate Plc's Q3 2024 earnings call highlighted challenges in revenue decline and net loss, with a focus on repositioning and value creation. The company is implementing a Value Creation Plan to optimize its business model and drive sustainable growth. Opportunities exist in improving sales execution, product innovation, and aligning the portfolio for enhanced profitability.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Clarivate Plc engages in the provision of global information, analytics, and workflow solutions. It operates through the following segments: Academia and Government (A&G), Intellectual Property (IP), and Life Sciences and Healthcare (LS&H). The A&G segment involves the provision of research and analytics, content aggregation, and workflow software solutions using artificial intelligence. The IP segment includes the maintenance, intelligence, and management solutions. The LS&H focuses on solutions for research and development, regulatory and safety, and commercialization. The company was founded in 1864 and is headquartered in London, the United Kingdom.

New report investigates how telehealth can reduce healthcare disparities in the treatment of Black Americans LONDON, Dec. 7, 2021 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today announced the release of a new report, entitled Realizing telehealth's potential to reduce healthcare disparities: How healthcare stakeholders can utilize technology to remedy inequities in the treatment of Black Americans . The new report centers on telehealth's role in addressing healthcare inequities in the United States and the most difficult challenges and potential solutions, examining how policymakers, providers and advocates are addressing these challenges to increase access to healthcare, specifically among Black Americans.

Clarivate Report Finds Telehealth Can Close Gaps in Care and Ease Disparities

The stock price of Clarivate (NYSE: CLVT) increased by over 11% during intraday trading today. This is why it happened.

Clarivate (CLVT) Stock: Why The Price Jumped Today

Dana Incorporated

MAUMEE, Ohio, Dec. 1, 2021 /PRNewswire/ -- Dana Incorporated (NYSE: DAN) today announced the appointment of Dana veteran Timothy R. Kraus as senior vice president and chief financial officer.

Dana Incorporated Names New Chief Financial Officer

LONDON, Dec. 1, 2021 /PRNewswire/ -- Clarivate plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today announced a change to our executive leadership team. Clarivate Executive Vice President and Chief Financial Officer Richard Hanks is leaving the company and will be succeeded by Jonathan Collins, who is currently Executive Vice President and CFO of Dana Incorporated (NYSE: DAN).

Clarivate Announces Change in Executive Leadership

LONDON, Dec. 1, 2021 /PRNewswire/ -- Clarivate plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, has completed its acquisition of ProQuest – a leading global software, content, data and analytics provider. This succeeds the satisfaction of customary closing conditions, following a commitment to acquire the business from the Cambridge Information Group and other investors, announced on May 17, 2021.

Clarivate Successfully Completes Acquisition of ProQuest

LONDON, Nov. 24, 2021 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, announced today that Jerre Stead, Executive Chairman and Chief Executive Officer, and Richard Hanks, Chief Financial Officer, will present at the following virtual investor conferences in November and December 2021. BofA Securities Leveraged Finance Conference 2021 on Tuesday, November 30, 2021 at 8:15 am Eastern Time.

Clarivate to Present at Upcoming Investor Conferences in November and December 2021

Mainland China has nearly doubled its share of Highly Cited Researchers in four years LONDON, Nov. 16, 2021 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, unveiled its 2021 list of Highly Cited Researchers™ today. The methodology that determines the "who's who" of influential researchers draws on the data and analysis performed by bibliometric experts and data scientists at the Institute for Scientific Information™ at Clarivate.

Clarivate Identifies the One in 1,000 Citation Elite with Annual Highly Cited Researchers List

LONDON, Nov. 12, 2021 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, announced today that Jerre Stead, Executive Chairman and Chief Executive Officer, and Richard Hanks, Chief Financial Officer, will present at the following virtual investor conferences in November 2021. RBC Capital Markets Global Technology, Internet, Media and Telecom Virtual Conference on Wednesday, November 17, 2021 at 9:35 am Eastern Time.

Clarivate to Present at Upcoming Investor Conferences in November 2021

Seven steps to highly effective journey mapping for a great customer and partner experience LONDON, Nov. 10, 2021 /PRNewswire/ -- Clarivate Plc  (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, has been cited by Forrester in their recently published B2B2C Journey Mapping reports. The two reports, B2B2C Journey Mapping: Mapping The End- Customer Experience and B2B2C Journey Mapping: Mapping The Partner Experience, mention Clarivate Customer Experience (CX) Services insights on journey mapping.

Clarivate Cited in B2B2C Journey Mapping Reports by Independent Research Firm

Bioanalytical approach to accelerate development efforts in the identification of compounds that can treat chlorine or sulfur mustard injuries LONDON, Nov. 8, 2021 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today announced a new partnership with the Biomedical Advanced Research and Development Authority (BARDA), which provides an integrated, systematic approach to the development of the necessary vaccines, drugs, therapies, and diagnostic tools for public health medical emergencies. The new collaboration will leverage Clarivate Consulting Service's computational approach in identifying therapeutics for potential repurposing as medical countermeasures (MCMs) against chlorine and sulfur mustard induced injuries.

BARDA and Clarivate Partner to Identify Therapeutics Which Can Be Repurposed as Medical Countermeasures to Chemical Exposure

LONDON, Nov. 5, 2021 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, has been named in Inc's first annual Best-Led Companies list. The data-driven list of the strongest U.S. firms with revenue of $50 million to $2 billion looks at a 12-point measure of management excellence across the middle market.

Clarivate Named in Inc.'s First-Annual Best-Led Companies

LONDON, Nov. 2, 2021 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, announced today it will hold a Virtual Investor Day on Tuesday, November 9, 2021. Management will provide an update on the business, with presentations starting at 10:00 AM Eastern Time and concluding at approximately 1:00 PM Eastern Time.

Clarivate to Host Virtual Investor Day on November 9, 2021

Clarivate Plc (CLVT) CEO Jerre Stead on Q3 2021 Results - Earnings Call Transcript

Clarivate PLC (CLVT) delivered earnings and revenue surprises of 0.00% and -1.10%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

Clarivate PLC (CLVT) Meets Q3 Earnings Estimates

Combined IP management and IP intelligence frees up team to focus on strategy LONDON, Oct. 28, 2021 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, announced today that Hewlett Packard Enterprise (HPE) has chosen Clarivate as its IP lifecycle management partner. HPE currently owns a very large patent and trademark portfolio.

Hewlett Packard Enterprise Chooses Clarivate as IP Lifecycle Management Partner

LONDON, Oct. 28, 2021 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today announced that its Board of Directors has approved the extension of its share repurchase program through January 31, 2022. The current share repurchase program authorized the Company to purchase up to $250 million of its ordinary shares through open-market purchases, of which $185 million remains available, and was previously set to expire October 31, 2021.

Clarivate Announces Extension of $250 Million Share Repurchase Program

LONDON, Oct. 28, 2021 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT) (the "Company" or "Clarivate"), a global leader in providing trusted information and insights to accelerate the pace of innovation, today reported results for the third quarter ended September 30, 2021. Third Quarter 2021 Financial Highlights Revenues of $442.1 million and Adjusted Revenues(1) of $442.2 million, increased 55% and 54%, respectively, at constant currency Organic revenues(1), which exclude the impact of acquisitions and divestitures, increased 3%, at constant currency Net income of $0.9 million improved 100%; Net income per diluted share of $0.00 improved $0.47 Adjusted Net Income(1) of $113.6 million increased 94%; Adjusted Income per diluted share(1) (EPS) of $0.16 increased 14% or $0.02.

Clarivate Reports Third Quarter 2021 Results

Clarivate PLC (CLVT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Clarivate PLC (CLVT) Earnings Expected to Grow: Should You Buy?

Web of Science data uncovers links between G20 nations' response to COVID-19 and research subject diversity LONDON, Oct. 19, 2021 /PRNewswire/ --  Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today launched a new report which examines the research performance of each of the member countries of the G20 with a visual comparative snapshot for each nation. It also includes a special analysis of the G20 members' COVID-19 research as indexed in the Web of Science™ research publication and citation index.

Clarivate Measures Research Performance of the World's Leading Economies in Annual G20 Scorecard Report

LONDON, Oct. 18, 2021 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT; CLVT PRA), a global leader in providing trusted information and insights to accelerate the pace of innovation, today announced the appointment of Tiffani Shaw as Chief of Staff reporting to Jerre Stead, Executive Chairman and Chief Executive Officer at Clarivate. In this newly created role, Shaw will plan and direct administrative activities for the office of the CEO and be a member of the Executive Leadership Team.

Clarivate Names Tiffani Shaw as Chief of Staff

64 researchers named as 'Citation Laureates' have received Nobel honors since 2002 LONDON, Oct. 13, 2021 /PRNewswire/ --  Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today celebrates the five new Nobel Laureates across the fields of science and economics who were accurately identified as potential Nobel Prize recipients. Each individual was awarded the designation of Citation Laureate™ as much as 12 years prior to being named by the Nobel Assembly.

Clarivate Demonstrates 2021 Nobel Prediction Success in Every Field of Science and Economics

LONDON, Sept. 30, 2021 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, announced today it will report its financial results for the third quarter 2021 before the market opens on Thursday, October 28.

Clarivate to Report Third Quarter 2021 Results on October 28, 2021

New data on research landscape of 34 countries across South & Central America, Mexico and the Caribbean highlights benefits of an EU-style regional collaborative research organization LONDON, Sept. 30, 2021 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today released a report which examines the research landscape of a diverse region of 34 countries, across South and Central America, Mexico and the islands of the Caribbean, over four decades since 1981.

Clarivate Global Research Report Outlines Rising Impact in Latin America

LONDON, Sept. 22, 2021 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today named 16 world-class researchers from six countries as Citation Laureates™.

Clarivate Unveils Citation Laureates 2021 - Annual List of Researchers of Nobel Class

LONDON, Sept. 15, 2021 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today announced the release of the 2021 Centre for Medicines Research (CMR) International Pharmaceutical R&D Factbook.

2021 Centre for Medicines Research (CMR) Pharmaceutical R&D Factbook from Clarivate Finds Drug Approvals at a 10-year High Despite the Challenges of COVID-19

News for Clarivate Plc Stock (CLVT)